These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 34392462)

  • 41. Safety for Repeat Lumpectomy Without Radiotherapy for Ipsilateral Breast Tumor Recurrence.
    Ishitobi M; Fukui R; Hashimoto Y; Kittaka N; Nakayama T; Tamaki Y
    Anticancer Res; 2017 Sep; 37(9):5293-5299. PubMed ID: 28870967
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ipsilateral breast tumor recurrence (IBTR) after breast-conserving treatment for early breast cancer: risk factors and impact on distant metastases.
    Komoike Y; Akiyama F; Iino Y; Ikeda T; Akashi-Tanaka S; Ohsumi S; Kusama M; Sano M; Shin E; Suemasu K; Sonoo H; Taguchi T; Nishi T; Nishimura R; Haga S; Mise K; Kinoshita T; Murakami S; Yoshimoto M; Tsukuma H; Inaji H
    Cancer; 2006 Jan; 106(1):35-41. PubMed ID: 16333848
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cryoablation Therapy for Early-Stage Breast Cancer: Evidence and Rationale.
    Thai JN; Sevrukov AB; Ward RC; Monticciolo DL
    J Breast Imaging; 2023 Nov; 5(6):646-657. PubMed ID: 38141236
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lobular carcinoma in situ increases the risk of local recurrence in selected patients with stages I and II breast carcinoma treated with conservative surgery and radiation.
    Sasson AR; Fowble B; Hanlon AL; Torosian MH; Freedman G; Boraas M; Sigurdson ER; Hoffman JP; Eisenberg BL; Patchefsky A
    Cancer; 2001 May; 91(10):1862-9. PubMed ID: 11346867
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cryoablation of early-stage breast cancer: work-in-progress report of a multi-institutional trial.
    Sabel MS; Kaufman CS; Whitworth P; Chang H; Stocks LH; Simmons R; Schultz M
    Ann Surg Oncol; 2004 May; 11(5):542-9. PubMed ID: 15123465
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Young age is associated with ipsilateral breast tumor recurrence after breast conserving surgery and radiation therapy in patients with HER2-positive/ER-negative subtype.
    Kim HJ; Han W; Yi OV; Shin HC; Ahn SK; Koh BS; Moon HG; You JH; Son BH; Ahn SH; Noh DY
    Breast Cancer Res Treat; 2011 Nov; 130(2):499-505. PubMed ID: 21853352
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intraoperative irradiation for early breast cancer (ELIOT): long-term recurrence and survival outcomes from a single-centre, randomised, phase 3 equivalence trial.
    Orecchia R; Veronesi U; Maisonneuve P; Galimberti VE; Lazzari R; Veronesi P; Jereczek-Fossa BA; Cattani F; Sangalli C; Luini A; Caldarella P; Venturino M; Sances D; Zurrida S; Viale G; Leonardi MC; Intra M
    Lancet Oncol; 2021 May; 22(5):597-608. PubMed ID: 33845035
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Management of ipsilateral breast tumor recurrence following breast conservation surgery: a comparative study of re-conservation vs mastectomy.
    Van den Bruele AB; Chen I; Sevilimedu V; Le T; Morrow M; Braunstein LZ; Cody HS
    Breast Cancer Res Treat; 2021 May; 187(1):105-112. PubMed ID: 33433775
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Importance of margin width in breast-conserving treatment of early breast cancer.
    Bodilsen A; Bjerre K; Offersen BV; Vahl P; Amby N; Dixon JM; Ejlertsen B; Overgaard J; Christiansen P
    J Surg Oncol; 2016 May; 113(6):609-15. PubMed ID: 26991020
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Excision alone for small size ductal carcinoma in situ of the breast.
    Kim H; Noh JM; Choi DH; Lee J; Nam SJ; Lee JE; Park W; Huh SJ
    Breast; 2014 Oct; 23(5):586-90. PubMed ID: 24969239
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long-term Survival Comparison of Repeated Breast-conserving Surgery Versus Mastectomy for Patients with DCIS with Ipsilateral Breast Tumor Recurrence: A Real-world Longitudinal Study.
    Li Q; Wang K; Yang L; Wu Q; Zhu W; Li Z; Shi Y; Zhang X; Li H
    Clin Breast Cancer; 2021 Aug; 21(4):360-372. PubMed ID: 33846099
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prognosis after mastectomy versus repeat lumpectomy in patients with ipsilateral breast cancer recurrence: A propensity score analysis.
    Yoshida A; Takahashi O; Okumura Y; Arima N; Nakatsukasa K; Tanabe M; Shien T; Masuda N; Tanaka S; Komoike Y; Taguchi T; Iwase T; Nishimura R; Inaji H; Yamauchi H; Ishitobi M;
    Eur J Surg Oncol; 2016 Apr; 42(4):474-80. PubMed ID: 26853760
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Locoregional Recurrence by Tumor Biology in Breast Cancer Patients after Preoperative Chemotherapy and Breast Conservation Treatment.
    Jwa E; Shin KH; Kim JY; Park YH; Jung SY; Lee ES; Park IH; Lee KS; Ro J; Kim YJ; Kim TH
    Cancer Res Treat; 2016 Oct; 48(4):1363-1372. PubMed ID: 26910473
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The impact of lobular carcinoma in situ in association with invasive breast cancer on the rate of local recurrence in patients with early-stage breast cancer treated with breast-conserving therapy.
    Jolly S; Kestin LL; Goldstein NS; Vicini FA
    Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):365-71. PubMed ID: 16965988
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Surgical management of ipsilateral breast tumor recurrence.
    Kolben T; Schwarz TM; Goess C; Blume C; Degenhardt T; Engel J; Wuerstlein R; Ditsch N; Harbeck N; Kahlert S
    Int J Surg; 2015 Nov; 23(Pt A):141-6. PubMed ID: 26449651
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Positive surgical margins and ipsilateral breast tumor recurrence predict disease-specific survival after breast-conserving therapy.
    Meric F; Mirza NQ; Vlastos G; Buchholz TA; Kuerer HM; Babiera GV; Singletary SE; Ross MI; Ames FC; Feig BW; Krishnamurthy S; Perkins GH; McNeese MD; Strom EA; Valero V; Hunt KK
    Cancer; 2003 Feb; 97(4):926-33. PubMed ID: 12569592
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Primary chemotherapy for operable breast cancer: incidence and prognostic significance of ipsilateral breast tumor recurrence after breast-conserving surgery.
    Rouzier R; Extra JM; Carton M; Falcou MC; Vincent-Salomon A; Fourquet A; Pouillart P; Bourstyn E
    J Clin Oncol; 2001 Sep; 19(18):3828-35. PubMed ID: 11559720
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Omitting radiotherapy in women ≥ 65 years with low-risk early breast cancer after breast-conserving surgery and adjuvant endocrine therapy is safe.
    Wickberg Å; Liljegren G; Killander F; Lindman H; Bjöhle J; Carlberg M; Blomqvist C; Ahlgren J; Villman K
    Eur J Surg Oncol; 2018 Jul; 44(7):951-956. PubMed ID: 29709338
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ipsilateral breast tumor recurrence postlumpectomy is predictive of subsequent mortality: results from a randomized trial. Investigators of the Ontario Clinical Oncology Group.
    Whelan T; Clark R; Roberts R; Levine M; Foster G
    Int J Radiat Oncol Biol Phys; 1994 Aug; 30(1):11-6. PubMed ID: 8083103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.